Ascending Dose Tolerability/Safety of SLV308 for the Treatment of Parkinson's Disease

NCT00134251 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Solvay Pharmaceuticals